ASH 2005
Interviews and expert commentary from ASH 2005 — study authors and key opinion leaders discuss the findings and their clinical implications.
Audio Journal of Oncology
Rituximab Maintenance after Chemotherapy Gives Better Outcomes in Advanced Follicular Lymphoma
Sandra Horning Abstract 349 Sandra Horning, Stanford University Medical Center It is not necessary to use rituximab along with standard CVP (cyclophosphamide, vincristine, predinsone) induction therap
21 December 2005
0:00
Audio Journal of Oncology
Targeted Therapies in Multiple Myeloma Treatment Decisions
Vincent Rajkumar Vincent Rajkumar, Divison of Hematology, Mayo Clinic At a section of the hematology meeting talking about newly diagnosed multiple myeloma and the evolving treatments, Vincent Rajkuma
21 December 2005
5:04
Audio Journal of Oncology
Pro-Apoptosis, mTOR Pathways: New Targets for Lymphoma
Owen O’Connor Owen O’Connor, Memorial Sloan-Kettering Cancer Center, New York Owen O’Connor also gave data from early, two studies: one looking at treating lymphoma with the drug SAH
21 December 2005
0:00